WO2025237886 - COMPOSITION FOR PREVENTION AND TREATMENT OF INFLAMMATION OR IMPROVING IMMUNE REGULATION
National phase entry is expected:
Publication Number
WO/2025/237886
Publication Date
20.11.2025
International Application No.
PCT/EP2025/062873
International Filing Date
12.05.2025
Title **
[English]
COMPOSITION FOR PREVENTION AND TREATMENT OF INFLAMMATION OR IMPROVING IMMUNE REGULATION
[French]
COMPOSITION POUR LA PRÉVENTION ET LE TRAITEMENT D'UNE INFLAMMATION OU L'AMÉLIORATION DE LA RÉGULATION IMMUNITAIRE
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Inventors
WANG, Dantong
DOGRA, Shaillay Kumar
SPRENGER, Norbert
Priority Data
24175619.6
14.05.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1965 | |
| EPO | Filing, Examination, Granting | 8159 | |
| Japan | Filing, Examination, Granting | 2108 | |
| South Korea | Filing, Examination, Granting | 1927 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,899
Contact Us
Abstract[English]
The present invention relates to a combination comprising cellulose, xyloglucan and pectin in effective amount for use in preventing or treating an inflammatory condition and/or disease in a young individual, preferably in infant during weaning period. The present invention further relates to compositions and methods for preventing or treating an inflammatory condition and/or disease in a young individual, preferably in an infant during weaning period.[French]
La présente invention concerne une combinaison comprenant de la cellulose, du xyloglucane et de la pectine en quantité efficace pour une utilisation dans la prévention ou le traitement d'un état inflammatoire et/ou d'une maladie chez un jeune individu, de préférence chez le nourrisson pendant la période de sevrage. La présente invention concerne en outre des compositions et des méthodes de prévention ou de traitement d'un état inflammatoire et/ou d'une maladie chez un individu jeune, de préférence chez un nourrisson pendant la période de sevrage.